Response to: 'Can we further SPARkle the SPAR model?' by Kavadichanda et al

Ann Rheum Dis. 2019 Sep;78(9):e94. doi: 10.1136/annrheumdis-2018-213962. Epub 2018 Jul 21.
No abstract available

Keywords: methotrexate; systemic sclerosis; treatment.

Publication types

  • Letter
  • Comment

MeSH terms

  • Disease Progression
  • Humans
  • Lung Diseases, Interstitial*
  • Scleroderma, Systemic*